Abstract
Cell-based assays for the inhibition of viral infections most commonly couple a positive signal (e.g., an increase in fluorescence) to the infection itself and not to its inhibition. When performing drug screens, compounds decreasing the signal are therefore considered as putative inhibitors. However, this approach can cause the selection of many false positives, since, for example, both killing of the host cell and inhibiting viral cell-entry results in the same signal. Using a model system based on murine leukemia virus (MLV) particles pseudotyped with the G-protein of vesicular stomatitis virus (VSV-G), we have developed generic assays coupling a positive readout to the inhibition of viral transduction. Consequently, the system favors drug candidates (and concentrations thereof) that do not harm human cells and significantly decreases the probability for selecting false positives. The assay allows Z-factors of ∼0.9, takes cytotoxic side effects into account and could in theory be adapted for high-throughput screening of inhibitors against further viral species.
Keywords: High throughput screening, antivirals, cell-entry inhibitors, pseudotyped viruses, fluorescence assay
Combinatorial Chemistry & High Throughput Screening
Title: Coupling the Inhibition of Viral Transduction with a Positive Fluorescence Signal
Volume: 13 Issue: 4
Author(s): Jenifer Clausell-Tormos, Andrew D. Griffiths and Christoph A. Merten
Affiliation:
Keywords: High throughput screening, antivirals, cell-entry inhibitors, pseudotyped viruses, fluorescence assay
Abstract: Cell-based assays for the inhibition of viral infections most commonly couple a positive signal (e.g., an increase in fluorescence) to the infection itself and not to its inhibition. When performing drug screens, compounds decreasing the signal are therefore considered as putative inhibitors. However, this approach can cause the selection of many false positives, since, for example, both killing of the host cell and inhibiting viral cell-entry results in the same signal. Using a model system based on murine leukemia virus (MLV) particles pseudotyped with the G-protein of vesicular stomatitis virus (VSV-G), we have developed generic assays coupling a positive readout to the inhibition of viral transduction. Consequently, the system favors drug candidates (and concentrations thereof) that do not harm human cells and significantly decreases the probability for selecting false positives. The assay allows Z-factors of ∼0.9, takes cytotoxic side effects into account and could in theory be adapted for high-throughput screening of inhibitors against further viral species.
Export Options
About this article
Cite this article as:
Clausell-Tormos Jenifer, D. Griffiths Andrew and A. Merten Christoph, Coupling the Inhibition of Viral Transduction with a Positive Fluorescence Signal, Combinatorial Chemistry & High Throughput Screening 2010; 13 (4) . https://dx.doi.org/10.2174/138620710791054312
DOI https://dx.doi.org/10.2174/138620710791054312 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer
Current Pharmaceutical Design Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Dysglycemia and Abdominal Obesity
Current Vascular Pharmacology Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms
Anti-Cancer Agents in Medicinal Chemistry The Characteristic of Histopathology in Spondyloarthropathy
Current Rheumatology Reviews Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Novel Heterocyclic Hybrids Based on 2-Pyrazoline: Synthesis and Assessment of Anti-Inflammatory and Analgesic Activities
Current Organic Synthesis Selenium Derivatives as Cancer Preventive Agents
Current Medicinal Chemistry - Anti-Cancer Agents The Roles of the Unique Prolyl Isomerase Pin1 in Cancer-Related Viral and Bacterial Infections
Current Molecular Medicine Recent Patents on Implantable Drug/Protein Delivery Systems Fabricated Using Electrospinning
Recent Patents on Biomedical Engineering (Discontinued) Serine Proteinase Inhibitors in the Skin: Role in Homeostasis and Disease
Current Protein & Peptide Science Targeting Matrix Metalloproteinases in Inflammatory Conditions
Current Drug Targets Editorial [Hot Topic: Protective or Damaging Immunity in Infection (Guest Editors: Jose Gutierrez and Antonio Sorlozano)]
Current Immunology Reviews (Discontinued) Traumatic Stress Reactions in Parents in Pediatric Intensive Care: A Review
Current Psychiatry Reviews Hydroxyproline: A Potential Biochemical Marker and Its Role in the Pathogenesis of Different Diseases
Current Protein & Peptide Science Hsp70 in Oncology
Recent Patents on DNA & Gene Sequences Should we Try to Alleviate Immunosenescence and Inflammaging - Why, How and to What Extent?
Current Pharmaceutical Design Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Current Neuropharmacology Biocatalysis in the Pharmaceutical Industry. A Greener Future
Current Green Chemistry Proteins Structures in Leishmania Amastigotes for Clinical Remission of Psoriasis
Current Proteomics